Balanced-force shim system for correcting magnetic-field inhomogeneities in the heart due to implanted cardioverter defibrillators

BackgroundIn the US, 1.4 million people have implanted ICDs for reducing the risk of sudden death due to ventricular arrhythmias. Cardiac MRI (cMR) is of particular interest in the ICD patient population as cMR is the optimal imaging modality for distinguishing cardiac conditions that predispose to...

Full description

Bibliographic Details
Published in:	Frontiers in Medicine
Main Authors:	Mirko Hrovat, Aravindan Kolandaivelu, Yifan Wang, Anthony Gunderman, Henry R. Halperin, Yue Chen, Ehud J. Schmidt
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Subjects:	ICD defibrillator implant MRI metal artifacts shimming
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2024.1225848/full

Similar Items

In-bore Remotely-manipulated Cantilevered Cardiac Shim System (CSS) Corrects CMR Artifacts Due to Implanted Cardioverter Defibrillators (ICDs): Phantom and Swine Validation
by: Mirko Hrovat, PhD, et al.
Published: (2024-01-01)

Real-World Efficacy and Safety of the Subcutaneous Implantable Cardioverter Defibrillator: Insights from the GASP Registry
by: Nikias Milaras, et al.
Published: (2025-06-01)

Shim coils tailored for correcting B0 inhomogeneity in the human brain (SCOTCH): Design methodology and 48-channel prototype assessment in 7-Tesla MRI
by: Bruno Pinho Meneses, et al.
Published: (2022-11-01)

How does the ICD recognize the type of arrhythmia? Tachyarrhythmia discrimination in modern transvenous cardioverter defibrillators
by: Flóra Diána Gausz, et al.
Published: (2025-08-01)

Implantable Cardioverter Defibrillator Tachycardia Therapies: Past, Present and Future Directions
by: Andrew M. Leong, et al.
Published: (2024-03-01)

Inappropriate shocks by subcutaneous implantable cardioverter-defibrillator due to T-wave oversensing in hyperkalemia leading to ventricular fibrillation
by: Omid Kiamanesh, MD, et al.
Published: (2015-07-01)

Dynamic shimming in the cervical spinal cord for multi-echo gradient-echo imaging at 3 T
by: E. Alonso-Ortiz, et al.
Published: (2023-03-01)

Twiddler's syndrome: An unusual cause of repeated shocks by implantable cardioverter-defibrillator in an asymptomatic patient
by: Ahmad Jabri, et al.
Published: (2019-01-01)

Risk factors for the first and second inappropriate implantable cardioverter-defibrillator therapy
by: Nobuhiro Nishii, et al.
Published: (2021-06-01)

Improving T2*-weighted human cortico-spinal acquisitions with a dedicated algorithm for region-wise shimming
by: Ying Chu, et al.
Published: (2023-03-01)

Managing cross talk between a subcutaneous implantable cardioverter-defibrillator and a dual-chamber unipolar pacemaker system
by: Konstantinos Kossidas, MD, FHRS, et al.
Published: (2017-12-01)

Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case
by: Yasuhisa Nakao, et al.
Published: (2020-03-01)

Anatomical considerations for the nontransvenous implantable cardioverter-defibrillator implantation: A cadaver-based analysis
by: Peter Khalil, MD, FHRS, et al.
Published: (2025-10-01)

Fast-RF-Shimming: Accelerate RF shimming in 7T MRI using deep learning
by: Zhengyi Lu, et al.
Published: (2025-09-01)

Benefit of implantable cardioverter defibrillator use in Japanese patients based on modified MADIT‐ICD benefit score
by: Toshinori Chiba, et al.
Published: (2025-02-01)

Lead Extractions are not Necessarily Required in the Treatment of Cases with Local Complications Unproven Resional/systemic Infection at the Pacemaker/ implantable Cardioverter Defibrillator (ICD) Site
by: Ryoji Kishi, MD, et al.
Published: (2005-01-01)

Anxiety and depression in inherited channelopathy patients with implantable cardioverter-defibrillators
by: Sajya M. Singh, BS, et al.
Published: (2021-08-01)

Subcutaneous implantable cardioverter‐defibrillator: a systematic review of comparative effectiveness and safety
by: Sarah Wolf, et al.
Published: (2023-04-01)

Eligibility for subcutaneous implantable cardioverter‐defibrillator in adults with congenital heart disease
by: Christos Zormpas, et al.
Published: (2021-04-01)

MRS Shimming: An Important Point Which Should not be Ignored
by: B Zeinali-Rafsanjani, et al.
Published: (2018-09-01)

A case of pioneering subcutaneous implantable cardioverter defibrillator intervention in Timothy syndrome
by: Zixi Zhang, et al.
Published: (2024-11-01)

Factors Associated With Non-Uptake of Implantable Cardioverter-Defibrillator (ICD) Among Eligible Patients at a Tertiary Hospital in Kenya
by: Emmanuel Oluoch, et al.
Published: (2024-08-01)

Phoenix from the Ashes: An Advocacy for an International Consensus for Return To Play for Athletes with Implantable Cardioverter Defibrillators
by: Andreas Müssigbrodt
Published: (2025-07-01)

Clinical outcomes of subcutaneous vs. transvenous implantable defibrillator therapy in a polymorbid patient cohort
by: Badder Kattih, et al.
Published: (2022-10-01)

Active shim coils design for Halbach magnet based on inverse boundary element method
by: Yajie Xu, et al.
Published: (2022-08-01)

Cost-effectiveness and budget impact analyses of using implantable cardioverter-defibrillators in the Russian Federation
by: T. O. Bessonova, et al.
Published: (2022-04-01)

“I don’t know exactly what you’re referring to”: the challenge of values elicitation in decision making for implantable cardioverter-defibrillators
by: Carroll SL, et al.
Published: (2018-09-01)

Outcomes in Brugada Syndrome Patients With Implantable Cardioverter-Defibrillators: Insights From the SGLT2 Registry
by: Sharen Lee, et al.
Published: (2020-03-01)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
by: Temirkhan Begisbayev, et al.
Published: (2022-05-01)

A Numerical Analysis of the Nonlinear Dynamics of Shimmed Conical Gas Foil Bearings
by: Marian Sarrazin, et al.
Published: (2023-05-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

Stretch, Injury and Inflammation Markers Evaluation to Predict Clinical Outcomes After Implantable Cardioverter Defibrillator Therapy in Heart Failure Patients With Metabolic Syndrome
by: Celestino Sardu, et al.
Published: (2018-06-01)

Inappropriate defibrillator shock due to EMI despite noise reversion and SecureSense - What is the mechanism?
by: Sanjeev S Mukherjee, et al.
Published: (2022-03-01)

Implantable Cardioverter Defibrillator in Primary and Secondary Prevention of SCD—What We Still Don′t Know
by: Andreea Maria Ursaru, et al.
Published: (2022-04-01)

The wearable cardioverter defibrillator as a bridge to reimplantation in patients with ICD or CRT-D-related infections
by: L. Castro, et al.
Published: (2017-11-01)

Prognostic impact of implantable cardioverter defibrillators and associated adverse events in patients with continuous flow left ventricular assist devices
by: Jonas Pausch, et al.
Published: (2023-06-01)

Postoperative intravenous patient‐controlled analgesia improves pain management after subcutaneous implantable defibrillator implantation
by: Kenta Tsutsui, et al.
Published: (2024-04-01)

Ventricular tachycardia slower than the rate cut-off of a subcutaneous cardiac defibrillator sensed and successfully treated as a result of oversensing
by: Ali A. Sovari, MD, et al.
Published: (2017-02-01)

Long‐term safety and efficacy of subcutaneous implantable cardioverter‐defibrillator compared with transvenous implantable cardioverter‐defibrillator in propensity score‐matched patients from Japan
by: Yuki Konno, et al.
Published: (2025-04-01)